YbaƱez, Stephen B.
HRN: 22-47-97 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/22/2023
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
11/22/2023
11/29/2023
ORAL
1ml
TID
Fungal Infection
Checking Final Appropriateness
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes